Cardiologist Referrals Lower Cholesterol in Prostate Cancer Patients, No Heart Benefit

Men diagnosed with prostate cancer face an elevated risk of cardiovascular disease, a risk that intensifies when they receive hormone therapy as part of their treatment. A large, international study—the first of its kind—conducted by researchers at McMaster University examined whether routine referrals to an internist or cardiologist could mitigate this risk. The trial enrolled a diverse cohort of men across multiple countries and systematically directed participants to specialist care for cardiovascular assessment and management while they underwent standard prostate cancer treatment.

The findings showed that specialist referrals led to measurable improvements in cholesterol levels, indicating better control of a key cardiovascular risk factor. However, the enhanced lipid management did not translate into a reduction in major adverse cardiac events; rates of heart attacks, strokes, heart failure, and cardiovascular mortality remained comparable to those who received usual care without routine specialist involvement. The study underscores the complexity of addressing heart disease in prostate cancer patients and suggests that while lipid optimization is achievable, additional strategies may be required to lower the incidence of serious cardiovascular outcomes.